Toxoplasma seroprevalence in healthy voluntary blood donors from urban Karnataka

Indian Journal of Medical Research

Volumn 126, Issue 1, 2007, Pages 50-55

  Sundar, Periyavan ^a   Mahadevan, A ^a   Jayshree, R S ^b   Subbakrishna, D K ^a   Shankar, S K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

Seroprevalence; Toxoplasmosis; Voluntary blood donors

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTOZOON ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; BINDING AFFINITY; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INDIA; MALE; NORMAL HUMAN; PARASITE TRANSMISSION; PREVALENCE; SCREENING TEST; SEROPREVALENCE; TOXOPLASMA GONDII; TOXOPLASMOSIS; URBAN AREA; VOLUNTEER; ANIMAL; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; TOXOPLASMA;

ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; BLOOD DONORS; FEMALE; HUMANS; INDIA; MALE; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMA; TOXOPLASMOSIS;

EID: 35548968765     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Pinlaor S, Ieamviteevanich K, Pinlaor P, Maleewong W, Pipitgool V. Seroprevalence of specific total immunoglobulin (Ig), IgG and IgM antibodies to Toxoplasma gondii in blood donors from Loei province, Northeast Thailand. Southeast Asian J Trop Med Public Health 2000; 31: 123-7.
2. Coelho RA, Kobayashi M, Carvalho LB Jr. Prevalence of IgG antibodies specific to Toxoplasma gondii among blood donors in Recife, Northeast Brazil. Rev Inst Med Trop Sao Paulo 2003; 45: 229-31.
3. Liu Y, Zheng K, Chen M, Fu L, Du W, Shi Z. Study on detecting antibodies to Toxoplasma gondii in pooled serum of blood donors by Dot-IGSS. Southeast Asian J Trop Med Public Health 2001; 32: 558-61.
4. Yang HJ, Jin KN, Park YK, Hong SC, Bae JM, Lee SH, et al. Seroprevalence of toxoplasmosis in the residents of Cheju island, Korea. Korean J Parasitol 2000; 38: 191-3.
5. Zuber P, Jacquier P. Epidemiology of toxoplasmosis: worldwide status. Schweiz Med Wochenschr 1995; 65 (Suppl): 19S-22S.
6. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001; 154: 357-65.
7. de Araujo IF, Anna BS, Hyakutake S. Prevalence of anti- Toxoplasma gondii antibodies in blood donors of Natal (RN). Rev Farm Bioquim Univ Sao Paulo 1975; 13: 417-25.
8. McDonald CP, Barbara JA, Contreras M, Brown S. Provision of a panel of anti-toxoplasma-negative blood donors Vox Sang 1989; 57: 55-8.
9. Svobodova V, Literak I. Prevalence of IgM and IgG antibodies. to Toxoplasma gondii in blood donors in Czech Republic. Eur J Epidemiol 1998; 14: 803-5.
10. Al-Amari OM. Prevalance of antibodies to Toxoplasma gondii among blood donors in Abha, Asir Region, South-Western Saudi Arabia. J Egypt Public Health Assoc 1994; 69: 77-8.
11. Mittal V, Bhatia R, Sehgal S. Prevalence of Toxoplasma antibodies among women with BOH and general population in Delhi. J Comnum Dis 1990; 22: 223-6.
12. Singh S, Nautiyal BL. Seroprevalence of toxoplasmosis in Kumaon region of India. Indian J Med Res 1991; 93: 247-9.
13. Mohan B, Dubey ML, Malla N, Kumar R. Seroepidemiological study of toxoplasmosis in different sections of population of Union Territory of Chandigarh. J Commun Dis 2002; 34: 15-22.
14. Joshi YR, Vyas S, Joshi KR. Seroprevalence of toxoplasmosis in Jodhpur, India. J Commun Dis 1998; 30: 32-7.
15. Meisheri YV, Mehta S, Patel U. A prospective study of seroprevalence of toxoplasmosism general population and in HIV/AIDS patients in Bombay, India. J Postgrad Med 1977; 43: 93-7.
16. Singh S, Pandit AJ. Incidence and prevalence of toxoplasmosis in Indian pregnant women: a prospective study. Am J Reprod Immunol 2004; 52: 276-83.
17. Yashodhara P, Ramalakshmi BA, Lakshmi V, Krishna TP. Socioeconomic status and prevalence of toxoplasmosis during pregnancy. Indian J Med Microbiol 2004; 22: 241-3.
18. Hall SM. Congenital toxoplasmosis. Br Med J 1992; 305: 291-7.
19. Vasina SG, Dunaeva ZV. On the length of survival of Toxoplasma outside the host organism. Med Prom SSSR 1960; 29: 451-4.
20. Raisenan S. Toxoplasmosis transmitted by blood transfusion. Transfusion 1978; 18: 329-32.
21. Kimball AC, Kean BH, Kellner A. The risk of transmitting toxoplasmosis by blood transfusion. Transfusion 1965; 5: 447-57.
22. Siegel SE, Lunde MN, Gelderman AH, Halterman RH, Brown JA, Lovine AS, et al. Transmission of toxoplasmosis by leukocyte transfusion. Blood 1971; 37: 388-94.
23. Wreghitt TG, Hakim M, Gray JJ, Balfour AH, Stovin PG, Stewart S, et al. Toxoplasmosis in heart and heart and lung transplant recipients. J Clin Pathol 1989; 42: 194-9.
24. Slavin MA, Meyers JD, Remington JS, Hackman RC. Toxoplasma gondii infection in bone marrow transplant recipients: A 20 year experience. Bone Marrow Transplant 1994; 13: 549-57.
25. Singh S, Ahlawat S, Singh N, Chaudhury VP. High TORCH seroprevalence rate in multiply transfused α-thalassemic children in India. Eur J Haematol 1995; 54: 64-6.
26. Liley AW. Intra uterine transfusion of foetus in hemolytic disease. B M J 1963; 5365: 1167-9.
27. Ambroise-Thomas P, Pelloux H. Toxoplasmosis - congenital and in immunocompromised patients. A parallel. Parasitol Today 1993; 9: 61-3.